Publications database

Displaying 1 - 10 of 47

Europol–EMCDDA Joint report on a new psychoactive substance: 1-(3-chlorophenyl) piperazine (mCPP)

In August 2005, after examining the available information collected on mCPP (1-(3-chlorophenyl)piperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint report. The report concluded that...

2005 Annual report: the state of the drugs problem in Europe

The report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in...

Alternatives to imprisonment — targeting offending problem drug users in the EU

The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed...

Buprenorphine — treatment, misuse and prescription practices

Since the mid-1990s buprenorphine has increasingly become available in Europe as an alternative to methadone for the treatment of opiate dependence. In this Selected issue, the reasons why clinicians are attracted to...

Drug-related public nuisance — trends in policy and preventive measures

This Selected issue is not intended to present a systematic and exhaustive review either of all possible definitions of drug-related public nuisance or of all measures, provisions and policies aimed at reducing...

Illicit drug use in the EU: legislative approaches

The paper offers an overview of the current legal provisions on the use and possession of drugs for personal use in the EU Member States. The first part of the study focuses...

Monographs

In this catalogue, the EMCDDA showcases its series of scientific monographs which offer expert opinion and comprehensive research from leading drug specialists in the EU and other world regions. The publications are...

National report 2005: Denmark

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

National report 2005: Norway

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

National report 2005: United Kingdom

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...